Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation | The Journal of Headache and Pain | Full Text

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation | The Journal of Headache and Pain | Full Text

(c) kieferpix Getty Images iStock

Featured consensus article: Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

EHF recommends onabotulinumtoxinA as an effective and well-tolerated treatment of chronic migraine, preferably for patients who have tried 2 or 3 other migraine prophylactics before.